Curative
Category: AI in Healthcare
A health insurance provider offering a $0-deductible, $0-copay plan that incentivizes preventative care through a mandatory 'Baseline' health assessment. Curative was founded in 2020. The company is led by Fred Turner. Based in Austin, USA. Team size: 500-1000. Total funding raised: $157.15M. Latest round: Series B (Dec 2025). Key investors include Khosla Ventures, Y Combinator.
- Founded
- 2020
- Headquarters
- Austin, USA
- Team size
- 500-1000
- Total funding
- $157.15M
Value proposition
Eliminates financial barriers to healthcare by removing all out-of-pocket costs (deductibles and copays), encouraging early intervention and preventative care to lower long-term employer costs.
Products and solutions
Curative Health Plan ($0 deductible, $0 copay), The Baseline Visit (Mandatory preventative health screening), Curative Pharmacy (Integrated prescription services), AI-Powered Member Portal & Care Navigation App, Remote Patient Monitoring (RPM) Services
Unique value
The 'Baseline' requirement: Members must complete a preventative health visit within 120 days of enrollment to maintain $0 out-of-pocket benefits, effectively 'nudging' an entire population toward preventative care.
Target customer
Mid-to-large sized employers (51+ employees) looking for cost-effective, high-engagement health benefits for their workforce.
Industries served
Health Insurance (InsureTech), Employee Benefits, Preventative Medicine, Healthcare Technology
Technology advantage
Utilizes a vertically integrated model and AI-driven data analytics to identify high-risk members early, providing proactive care management and remote monitoring that reduces expensive emergency room visits and late-stage treatments.
How they differentiate
The 'Baseline' requirement: Members must complete a preventative health visit within 120 days of enrollment to unlock and maintain $0 out-of-pocket costs (no deductibles or copays), creating a unique 'nudge' toward early intervention.
Main competitors
Oscar Health, Gravie, Centivo, Sidecar Health
Key partnerships
MultiPlan (PHCS Network) for national provider access, Major Pharmacy Benefit Managers (PBMs), Y Combinator (Alumni network and early backing), Local health systems and clinical laboratories
Notable customers
Austin Independent School District (AISD), Mid-to-large Texas-based employers (51+ employees)
Major milestones
Founded in 2020 as a COVID-19 testing startup, Delivered over 35 million COVID-19 tests nationally, Pivoted to a full-stack health insurance provider in 2022, Achieved Unicorn status with a $1.3B valuation in December 2025, Led Austin's startup funding charts in December 2025 with a $150M Series B
Growth metrics
Achieved a $1.3B valuation in late 2025; transitioned from a diagnostics-heavy revenue model (35M+ COVID tests) to a recurring premium-based insurance model.
Market positioning
Disruptive InsurTech challenger targeting the employer-sponsored insurance (ESI) market for mid-to-large enterprises.
Geographic focus
United States (Primary focus on Texas, with active expansion into Florida and Georgia).
Patents and IP
Proprietary software architecture for member health tracking and AI-driven risk stratification; specific patent filings are generally held as trade secrets within their private InsureTech platform.
About Fred Turner
Fred Turner is a British scientist and entrepreneur who founded Curative in 2020. He is a Y Combinator alumnus and was previously recognized by the Science Council as one of the top 100 practicing scientists in the UK. Before Curative, he founded Shield Bio, a diagnostics startup focused on rapid antibiotic susceptibility testing. Under his leadership, Curative scaled from a startup to a national leader in COVID-19 testing, delivering over 35 million tests, before pivoting the company into a disruptive health insurance provider focused on preventative care and AI-driven member management.
Official website: https://curative.com